Jessica Allegretti, MD, from Brigham and Women's Hospital, identified high risk factors for progressive disease, reviewed monotherapy vs combination therapy, and emphasized on the importance of treat-to-target at the AIBD meeting.
Jessica Allegretti, MD, from Brigham and Women's Hospital, identified high risk factors for progressive disease, reviewed monotherapy vs combination therapy, and emphasized on the importance of treat-to-target at the AIBD meeting.
Jessica Allegretti, MD, from...